Business Context and Reporting Period
Company: Cardiff Oncology, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 7, 2021
Reporting Period: Event-based report regarding upcoming investor conference participation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is an informational filing regarding corporate events and does not contain financial statements or performance data.
Material Changes
No material financial changes or operational updates were reported in this filing. The document solely announces scheduled management appearances at industry conferences.
Guidance, Outlook, and Management Commentary
Upcoming Events:
- H.C. Wainwright 23rd Annual Global Investment Conference: September 13–15, 2021.
- 2021 Cantor Virtual Global Healthcare Conference: September 27–30, 2021.
- Mark Erlander, Ph.D., Chief Executive Officer.
- James Levine, Chief Financial Officer.
Investor Verification Checklist
- Verify the specific dates and times for the virtual 1x1 meetings via the company's investor relations website.
- Review the press release furnished as Exhibit 99.1 for any additional details on the presentation topics.
- Check subsequent filings (e.g., 10-Q or 10-K) for the actual financial metrics and operational updates likely to be discussed at these conferences.